HOME >> MEDICINE >> NEWS
Fred Hutchinson receives $9.7 million to lead early detection consortium

based breast-cancer screening tests.

"If cancer is detected when it is still localized, we can cure it virtually 100 percent of the time with surgery and targeted radiotherapy," she said. "Once it has spread, it requires chemotherapy and becomes much harder to treat successfully."

For example, solid tumors can be cured 90 percent of the time if they're detected and treated early, whereas cure rates for late-stage cancer are usually only about 10 percent.

Fred Hutchinson was selected to lead the consortium, McIntosh said, because it can provide the expertise and infrastructure necessary for moving the results of new proteomic technologies from the laboratory into the clinic.

" Once we determine how to systematically discover those markers characteristic of early cancer development, the next challenge will be to go out and conduct population-based studies to find out if using them clinically can save lives. Fred Hutchinson Cancer Research Center has been a leader in that aspect of early detection as well," McIntosh said The recent award a key part of Fred Hutchinson's Early Detection and Intervention Initiative launched last year through $4.4 million in private funding represents the latest in a series of major biomarker-research funding grants to institutions within the new consortium, underscoring their stature in the field of proteomics.

Last year, for example, the Pacific Northwest National Laboratory received $10.2 million from the National Institutes of Health to develop advanced instrumentation for studying large and complex protein sets, thus establishing PNNL as a worldwide base for proteomics research. In 2002, the Institute for Systems Biology received $19.8 million from the National Heart, Lung and Blood Institute to establish one of 10 NHLBI Proteome Research Centers in the nation.

CONSORTIUM LEADERSHIP

Fred Hutchinson Cancer Research Center Seattle,
'"/>

Contact: Kristen Woodward
kwoodwar@fhcrc.org
206-667-5095
Fred Hutchinson Cancer Research Center
13-Dec-2004


Page: 1 2 3 4 5 6

Related medicine news :

1. Fred Hutchinson uses IBM technology to help find genetic links to immune-system diseases
2. Fred Hutchinson Cancer Research Center study shows retinoids kill childhood brain tumor cells
3. Fred Hutchinson oversees two grants of nearly $8 million to develop blood test for breast cancer
4. Fred Hutchinson Research Center awarded $7 million grant
5. Fred Hutchinson receives $12.7 million to lead prostate-cancer consortium
6. Hutchinson Center receives $1.2 million from National Science Foundation to study plant genetics
7. Of vasectomies, vitamins and prostate-cancer risk: Hutchinson Center study examines the links
8. Fred Hutchinson Cancer Research Center And Targeted Genetics Corp. Publish Data On Adoptive Immunotherapy For HIV
9. UIC professor receives international humanitarian award
10. Mailman School of Public Health receives Manhattan Tobacco Cessation Center grant
11. Epidemiologist Trichopoulos receives $5.8 million Department of Defense Innovator Award

Post Your Comments:
(Date:9/4/2015)... Los Angeles, CA (PRWEB) , ... September 04, 2015 , ... ... new material has been developed that changes color when subjected to an impact force ... article notes, could be implemented in helmets or other sporting equipment so that coaches ...
(Date:9/4/2015)... ... September 04, 2015 , ... The Schmidt National Law Group ... La Paz. , Schmidt National Law Group, a leading firm in mass-tort litigation, ... against Bayer Corp., Bayer Essure, Inc., and other Bayer affiliates for injuries alleged to ...
(Date:9/4/2015)... ... September 04, 2015 , ... Inmar announced ... joint meeting of its Product, Quality and Manufacturers, Dietary Supplements and Supply Chain ... evolving in the consumer goods industry, it can be difficult for companies to ...
(Date:9/4/2015)... ... 2015 , ... “Getting away from the daily stressors and distractions of life ... their ‘couple-ness,’” says Jean Claude Wietzel, general manager at Four Seasons Resort Maui ... only Forbes Five Star resort and Travel + Leisure’s No. 1 Hotel in Hawaii, ...
(Date:9/4/2015)... ... 2015 , ... The conference program for the upcoming Integrative ... 2015 at the Diplomat Resort & Spa has been announced and is available ... the top of their field and will be presenting sessions such as What ...
Breaking Medicine News(10 mins):Health News:New Article on Head Injury Detection Technology Highlights Implications for Head Injury Detection in Sports, says The Law Offices of Burg & Brock 2Health News:Schmidt National Law Group Files First Bayer Essure® Lawsuit in California 2Health News:Inmar Experts To Address OTC Manufacturers’ Session on Hazardous Waste and Handling at CHPA Meeting 2Health News:Inmar Experts To Address OTC Manufacturers’ Session on Hazardous Waste and Handling at CHPA Meeting 3Health News:Couples Season at Four Seasons Resort Maui Begins This Week With Best Hotel Rates of the Year through November 2Health News:Couples Season at Four Seasons Resort Maui Begins This Week With Best Hotel Rates of the Year through November 3Health News:Integrative Healthcare Symposium Focus On: The Microbiome Conference Program Announced 2
(Date:9/4/2015)... Future Prospects for Companies in Antihistamines, Corticosteroids, ... - new study showing you trends, partnerships, and ... allergic rhinitis drugs heading? What are the commercial prospects ... you potential revenues and other trends to 2025, discussing ... report provides 273 tables, charts, and graphs. Discover the ...
(Date:9/4/2015)... , Sep. 04, 2015 ... of the "Investigation Report on China,s Sodium Ibandronate Market, ... and used in the clinic under the trade name of ... Austria in 1996, sodium ibandronate was approved by ... treatment of osteoporosis under the trade name of Boniva. However, ...
(Date:9/4/2015)... September 4, 2015 Hutchison ... that Hutchison MediPharma Limited ("HMP"), its drug R&D ... second proof-of-concept ("POC") trial of fruquintinib in patients ... in China .  The top-line ... meeting the primary efficacy endpoint of progression free ...
Breaking Medicine Technology:Allergic Rhinitis Drugs Market Forecast 2015-2025 2Allergic Rhinitis Drugs Market Forecast 2015-2025 3Allergic Rhinitis Drugs Market Forecast 2015-2025 4Allergic Rhinitis Drugs Market Forecast 2015-2025 5Allergic Rhinitis Drugs Market Forecast 2015-2025 6Allergic Rhinitis Drugs Market Forecast 2015-2025 7Investigation Report on China's Sodium Ibandronate Market 2010-2019 2Second Proof-of-concept Trial of Fruquintinib Achieves its Primary Endpoint 2Second Proof-of-concept Trial of Fruquintinib Achieves its Primary Endpoint 3
Cached News: